Real-World Data Confirm Pazopanib as Safe, Effective in mRCC
Investigators conducted a noninterventional, multicenter study (APOLON) in patients receiving frontline pazopanib therapy.
Lea Eslava-Kim, PharmD
Drug Information Specialist https://www.renalandurologynews.com
Lea Eslava-Kim, PharmD, is a Drug Information Specialist for MPR. She received her doctorate in pharmacy from the Ernest Mario School of Pharmacy, Rutgers University and completed her pharmacy residency at Clara Maass Medical Center. She is a licensed pharmacist.
